ArticleJTO clinical and research reports2025

Early Weight Gain as a Risk Factor for Increased Maximum Weight Gain Among Patients With NSCLC on Lorlatinib and Other ALK Tyrosine Kinase Inhibitors.

Alexander S Watson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.